An Open Label, Randomized Study Prospectively Examining the Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin.
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Anxiety
- Focus Therapeutic Use
- 12 Sep 2017 Status changed from completed to discontinued.
- 24 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2013 Planned end date changed from 1 Jun 2012 to 1 Apr 2014 as reported by ClinicalTrials.gov.